Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet

DRUG2 trials

Sponsors

Galenicum Health

Conditions

BioequivalenceDiabetes Mellitus, Type 2

Phase 1

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

CompletedNCT06124495

Galenicum HealthBioequivalence, Diabetes Mellitus, Type 2

Start: 2023-01-13End: 2023-02-13Updated: 2023-11-09

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

CompletedNCT06124547

Galenicum HealthBioequivalence, Diabetes Mellitus, Type 2

Start: 2023-01-16End: 2023-02-13Updated: 2023-11-09